GlassScriptPhysician profile
Soledad C Griffin
NPI 1154378156
$628.10
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.36 · 2020: $64.26 · 2021: $109 · 2022: $136 · 2023: $146 · 2024: $74.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $138.93 | 2021-2022 | |
| Eisai INC. | $69.44 | 2022-2023 | |
| Seagen INC. | $65.16 | 2022-2023 | Padcev |
| Novartis Pharmaceuticals Corporation | $47.86 | 2023 | |
| Daiichi Sankyo INC. | $45.84 | 2020-2024 | Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $41.50 | 2019-2020 | |
| Mirati Therapeutics, INC. | $31.81 | 2024 | Krazati |
| Lilly USA, LLC | $25.96 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $24.24 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.64 | 2022 | |
| Aveo Pharmaceuticals, INC. | $19.93 | 2024 | |
| Abbvie INC. | $18.32 | 2020 | |
| Servier Pharmaceuticals LLC | $17.98 | 2023 | |
| Jazz Pharmaceuticals INC. | $17.13 | 2023 | |
| Healthmyne, INC. | $16.05 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $12.79 | 2019 | |
| Exelixis INC. | $12.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soledad Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.